Home › POZEN Rating Increased to Buy at Ascendiant Capital Markets
 

Keywords :   


POZEN Rating Increased to Buy at Ascendiant Capital Markets

2014-08-09 22:40:07| Biotech - Topix.net

The firm currently has a $10.00 price target on the stock. Ascendiant Capital Markets' price target would suggest a potential upside of 22.25% from the company's current price.

Tags: buy rating capital increased

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.07Tropical Storm Beryl Public Advisory Number 36A
07.07Summary for Tropical Storm Beryl (AT2/AL022024)
07.07Atlantic Tropical Weather Outlook
07.07Eastern North Pacific Tropical Weather Outlook
07.07Tropical Storm Beryl Potential Storm Surge Flooding Map
07.07Tropical Storm Beryl Probabilistic Storm Surge Graphics
07.07Tropical Storm Beryl Storm Surge Watch/Warning Map
07.07Tropical Storm Beryl Graphics
More »